FIGX Capital Acquisition Corp. (FIGX) 股票分析
金融服务FIGX Capital Acquisition Corp.
$10.22
+$0.00 (+0.00%)
最后更新: 2026年5月26日
价格走势
暂无价格数据
分析
公司概述
FIGX Capital Acquisition Corp. operates as a special purpose acquisition company (SPAC) within the financial services sector, specifically classified under the industry of shell companies, which indicates its primary function is to facilitate future business combinations rather than maintaining significant ongoing operations. The company was incorporated in 2025 with the strategic intent to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, positioning it as a vehicle for potential future corporate restructuring. As of the latest data, the entity holds a market capitalization of $195.99M, while specific figures for annual revenue and employee count are not disclosed in the available financial records. This market capitalization of approximately $196 million reflects the total market value of the company's outstanding shares, serving as a key indicator of its relative size within the shell company space, though the lack of reported revenue suggests the valuation is driven entirely by its potential for future mergers rather than current operational cash flows.
财务健康
The reported net income for the trailing twelve months stands at $3.00M, while revenue and EBITDA figures are not available in the provided data, creating a distinct financial profile where profitability exists independently of standard revenue generation metrics. The absence of reported free cash flow data precludes a direct assessment of current operational cash generation, yet the company maintains a substantial cash balance of $905,141, which provides a tangible liquidity buffer for transaction costs or deal-related expenses. Analysis of the three primary margins reveals a gross margin of 0.0%, an operating margin of 0.0%, and a profit margin of 0.0%, indicating that while the company reports net income, these specific margin calculations likely reflect the accounting treatment of SPAC structures where operating expenses may not be allocated against revenue in the traditional sense. In terms of leverage, the company reports zero total debt, resulting in a debt-to-equity ratio that is not applicable, which places the balance sheet in a highly conservative position with no interest obligations weighing on its financials. The current ratio is reported at 9.32, a figure that signifies an exceptionally strong short-term liquidity position, as current assets are 9.32 times greater than current liabilities, ensuring ample coverage for immediate obligations. Although return on equity and return on assets are listed as not available, the reported net income of $3.00M against the existing cash reserves suggests a capacity to generate earnings, albeit in a manner distinct from traditional operating businesses. The profit margin of 0.0% combined with positive net income highlights the unique accounting dynamics of shell companies where net income may stem from other comprehensive income or specific transactional accounting rather than standard operational profitability.
估值评估
The trailing P/E ratio and forward P/E ratio are both not available, a common characteristic for SPACs that have not yet completed an initial public offering or merger, which implies that earnings-based valuation multiples cannot be used to assess future earnings trajectories or growth expectations. The price-to-book ratio is recorded at -35.60, a negative figure that indicates the company's market capitalization is significantly below its book value, a scenario often seen in shell companies where the balance sheet assets (primarily cash) exceed the market value of the equity, suggesting a discount relative to tangible net assets. Since price-to-sales and EV/EBITDA metrics are not available, alternative valuation methods must rely on the market capitalization of $195.99M and the 52-week price range to gauge investor sentiment. The stock's 52-week high is $10.16 and the 52-week low is $9.95, establishing a narrow trading range of approximately $0.21 over the last year. Without a specific current share price provided in the facts, the price sits within this tight band, bounded by a high of $10.16 and a low of $9.95, reflecting the speculative nature of the asset class. The beta value is not available, preventing a direct comparison of the stock's price volatility relative to the broader market, though the narrow 52-week range of $10.16 down to $9.95 suggests limited price movement and low volatility in the short term. The negative price-to-book ratio of -35.60 further underscores that the market values the equity at a level far below the underlying cash holdings, which is typical for pre-business-combination SPACs.
Growth & Income
Revenue growth year-over-year and earnings growth year-over-year are both not available in the current dataset, which is expected for a company that has not yet executed a business combination and therefore has no historical growth trajectory to measure against. Because the company has not yet merged with an operating business, it does not pay dividends, resulting in a dividend yield and payout ratio that are not applicable, meaning all available capital is theoretically available for reinvestment into a future target company. The lack of reported revenue growth means that the entity is in the pre-revenue stage of its lifecycle, where value is derived from the prospect of a future merger rather than current earnings expansion. Consequently, the overall growth and income profile of FIGX Capital Acquisition Corp. is defined entirely by its potential to execute a business combination, rather than any existing operational performance or dividend distribution history.
同行比较
FIGX Capital Acquisition Corp. (FIGX) 在壳公司行业运营。以下是其与市值最接近的同行的比较:
| 公司 | 代码 | 市值 | 市盈率 |
|---|---|---|---|
| FIGX Capital Acquisition Corp. | FIGX | $198.12M | N/A |
| Twenty One Capital, Inc. | XXI | $2.49B | N/A |
| Churchill Capital Corp X | CCCX | $711.00M | N/A |
| Drugs Made In America Acquisition II Corp. | DMII | $641.46M | 77.5 |
壳公司行业平均市盈率为82.8倍。FIGX Capital Acquisition Corp.的市盈率为N/A。
本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。
相关壳公司股票
Twenty One Capital, Inc.
$2.49B
CCCXChurchill Capital Corp X
$711.00M
DMIIDrugs Made In America Acquisition II Corp.
$641.46M
BCSSBain Capital GSS Investment Corp.
$595.68M
EVACEQV Ventures Acquisition Corp. II
$594.41M
CEPFCantor Equity Partners IV, Inc.
$591.50M
金融服务热门股票
Berkshire Hathaway Inc.
$1.38T
BRK-BBerkshire Hathaway Inc.
$1.04T
BRK-ABerkshire Hathaway Inc.
$1.04T
JPMJPMorgan Chase & Co.
$821.91B
VVisa Inc.
$620.88B
关于FIGX Capital Acquisition Corp.
FIGX Capital Acquisition Corp. does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. FIGX Capital Acquisition Corp. was incorporated in 2025 and is based in Tiburon, California.
公司简介以英文显示。